Colesevelam: A Viewpoint by James Shepherd

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.1, Iss.2, 2001-01, pp. : 147-148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Colesevelam

By Melian E.B. Plosker G.L.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 2, 2001-01 ,pp. : 141-146

Adis International

Access to resources Recommend Favorite

Zaleplon: A Viewpoint by James K. Walsh

By Walsh J.K.

CNS Drugs, Vol. 11, Iss. 5, 1999-05 ,pp. : 393-394

Adis International

Access to resources Recommend Favorite

Desloratadine: A Viewpoint by James H. Day and Elizabeth Rafeiro

By Day J.H. Rafeiro E.

Drugs, Vol. 61, Iss. 6, 2001-01 ,pp. : 797-797

Adis International

Access to resources Recommend Favorite

Recombinant Full-Length Parathyroid Hormone (1-84): A Viewpoint by James Whitfield

By Whitfield James

Drugs, Vol. 66, Iss. 18, 2006-01 ,pp. : 2382-2385

Adis International

Access to resources Recommend Favorite

Colesevelam: A Review of its Use in Hypercholesterolemia

By Robinson Dean M. Keating Gillian M.

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 6, 2007-01 ,pp. : 453-465

Adis International

Access to resources Recommend Favorite